Novotech

Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations. 

Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide. 

Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies. 

Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results.

novotech-cro.com

 

Evinova

Evinova empowers life science leaders to accelerate better health outcomes. Purpose-built by healthcare for healthcare, Evinova delivers intelligently designed digital and AI-native solutions that optimize the entire clinical development lifecycle from end to end. With proven outcomes published in Nature Medicine, Evinova’s solutions and strategies have demonstrated up to 60% improvement in patient experience, 6-month acceleration in trial delivery, and 32% reduction in costs. Evinova is a separate health tech company within the AstraZeneca group. Learn more about Evinova at www.evinova.com or on social media @Evinova.

 

Fortrea

Fortrea is a leading global clinical research organization (CRO) with over 30 years of clinical research experience, providing comprehensive Phase I-IV trial management, clinical pharmacology, and consulting services across 20+ therapeutic areas. Evolved from Covance and Labcorp, Fortrea is built for biotech and biopharma, medical device and diagnostic innovators, delivering agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions in about 100 countries. We combine scientific rigor and operational excellence with innovation to help bring therapies from pipeline to patient. Together, exceptional is possible. For more information about Fortrea, please follow our official WeChat account or contact us via email: BD-CN@fortrea.com

 

Labcorp

Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world.

www.labcorp.com

 

MERIT

MERIT 迈睿 是一家创新型全球临床试验终点服务提供机构，聚焦肿瘤科、眼科、呼吸科等治疗领域。依靠数十年累积的经验，我们能够快马加鞭、全力以赴开展项目，出色的项目成果令客户感到放心和满意；MERIT迄今已为全球20家顶级制药公司中的13家提供助力，是绝对值得客户信赖的研发合作伙伴。MERIT在威斯康星州麦迪逊、中国上海、加拿大多伦多和澳大利亚悉尼均设有办事处。

www.meritcro.cn

 

Taimei Technology

Taimei Technology (02576.HK) is a leading AI-powered drug clinical development platform.Taimei combines full-stack AI capabilities with over a decade of deep expertise in clinical development. The company has developed a proprietary vertical-specific large language mode, giving rise to the "Wensi" AI Platform. This platform delivers trusted, usable, and perceivable AI agents and end-to-end AI-powered solutions to customers worldwide, enabling faster, more successful new drug development. Headquartered in China, Taimei Technology operates branch offices in the United States, Singapore and Korea. The company has provided digital and intelligent solutions to over 1,600 pharmaceutical companies and CROs globally, while maintaining a leading market share for its core products in China.

www.taimei.com

 

Almac

Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle.
We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.
We are recognised as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.
Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 5 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 30% of EU approved /pre-registered Gene therapy products.
A privately owned organisation, Almac has grown organically over the past five decades, employing over 7,700 highly skilled employees across 18 facilities in Europe, North America, and Asia. Learn more about us at www.almacgroup.com.

 

 

Catalent

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries. Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world. 

china.catalent.com / clinical.catalent.com

 

Shanhu Health

Shanhu Health provides high-quality digital products and solutions, including IP4CAST, IRT, WMS, EDC, eCOA, ePayment and drug management services, powered by an AI agent for intelligent and efficient operations. As a leading provider of clinical data and integrated drug management solutions in China, Shanhu has supported over 2,000 clinical studies across over 1,000 cities, 2,000 institutions, and 2 million participants worldwide, many of which were Phase III trials.

www.ishanhu.com

 

Syneos Health

Syneos Health is the only fully integrated biopharmaceutical solutions organization with a unique approach. At Syneos Health, all the disciplines involved in bringing new therapies to market, from clinical to commercial, work together with a singular goal — greatly increasing the likelihood of customer success. We call our business model Biopharmaceutical Acceleration. You can call it the future.

www.syneoshealth.com

 

Tigermed

Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 3,600 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees across Asia Pacific, Europe, North America, Latin America and Africa. We are devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.​

www.tigermedgrp.com

 

VCLS Voisin Consulting Life Sciences

VCLS (Voisin Consulting Life Sciences) is a specialist life sciences product development partner helping biotech, pharmaceutical, and medical device innovators advance complex products through regulated development and toward patient access.

VCLS supports clients across regulatory strategy, clinical research, vigilance, real-world evidence, market access, medical, scientific, and commercial communications, and lifecycle management, helping organizations navigate complex development decisions, transform data into evidence, and support evidence and value generation.

voisinconsulting.cn

 

Xincere Med Tech

Shanghai Xincere Med Tech Inc. delivers a Decentralized/Digitalized Clinical Trial (DCT) platform solution that integrates international quality, localization, and professional expertise, dedicated to developing a patient-centric, remote, and intelligent clinical research platform. Our core products and services include:eCOA (Electronic Clinical Outcome Assessment); Integrated Solution (ePData);Electronic Patient Diary (ePDiary);Electronic Informed Consent (ePConsent);Remote Visit System (ePVisit);Wearable Device Connectivity (ePLink). Additionally, Xincere offers compliant, scientific, and professional Scale Management and Rater Training services.

In 2024, we officially launched our DCT SaaS platform (ePData 2.0), which significantly reduces the complexity of traditional eCOA implementation and shortens project deployment cycles, providing a more accessible digital solution for clinical research in China.Xincere’s DCT products have been adopted in over 90 registered clinical trial projects, with multiple projects successfully passing inspections by the National Medical Products Administration (NMPA). Our solutions span over 60 disease areas, serving more than 25,000 patients, and have accelerated the successful market launch of multiple new drugs.

www.xinceremed.com